NYSE Content Update: Michael + Susan Dell to Ring Opening Bell with Invest America
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 25, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Verily...
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics. The agreement relates to...
Heidi Receives Frost & Sullivan’s 2026 North American Technology Innovation Leadership Recognition for Excellence in Artificial Intelligence Medical Scribe Innovation
The recognition highlights Heidi's leadership in clinical AI innovation, market impact, and customer-centric technology design. SAN ANTONIO, March 25, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Heidi has been recognized with the 2026 North America Technology Innovation Leadership Recognition in the Artificial Intelligence Medical Scribe industry for its outstanding achievements in innovation, strategy execution, and clinician...
Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation
The company is acknowledged for its scalable technology platform, application diversity, and customer-centered commercialization driving multi-industry adoption. SAN ANTONIO, March 25, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Locus FS has been honored with the 2026 North American Technology Innovation Leadership Recognition in the precision fermentation sector for its outstanding achievements in product development, technology-led...
Axtria Recognized as Frost & Sullivan’s 2025 Global Company of the Year in Pharma Commercial Solutions
Honored for AI-Driven Innovation, Measurable Client Impact, and Industry-Leading Commercialization Excellence BERKELEY HEIGHTS, N.J., March 25, 2026 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, has earned Frost & Sullivan's 2025 Global Company of the Year Recognition in the pharma commercial solutions industry, the...
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the special committee of its board of directors (the "Special Committee") has received...
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the development and commercialization of subcutaneous (SC) formulations of biologics utilizing ALT-B4 powered by Alteogen's...
Bioptimus Announces STELA: The World’s Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today The Launch of STELA: Bioptimus is establishing the largest clinically linked multimodal atlas, starting in oncology and immunology...
ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems
Offering a new, validated CCS design pathway, reducing uncertainty for cautious battery engineers NECKARSULM, Germany, March 25, 2026 /PRNewswire/ -- ENNOVI, a global leader in e-mobility interconnects and an engineering partner to the automotive industry, today announced the approval of a German patent for its innovative adhesive-free lamination technology for battery cell contacting systems (CCS). The laser lamination technology...
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual results for 2025, demonstrating record growth and a transformative leap in operational sophistication. The company reported a 16.7% increase in revenue, an IFRS gross profit growth of 30.9%, a 5 percentage-point expansion to 46.0%...
